Integrating findings from a prior study wherein P4HA2 was identified as promoting B-cell lymphoma in tumor cells, and the current study revealing its high expression in the stromal fibroblasts of B-cell lymphoma, emphasizes P4HA2 as a promising target for therapeutic intervention. This evidence concerns the gene P4HA2 and B-cell non-Hodgkin lymphoma.